Literature DB >> 17124891

Penetrating keratoplasty for keratoconus: the nexus between corneal wavefront aberrations and visual performance.

Konrad Pesudovs1, Douglas J Coster.   

Abstract

PURPOSE: To compare the visual and optical performance after penetrating keratoplasty (PK) for keratoconus to normal patients and to examine the relationship between corneal wavefront aberrations and visual performance in patients with PK.
METHODS: Visual performance testing, with optimal refractive correction, included low contrast visual acuity (LCVA) and Pelli-Robson contrast sensitivity with and without glare, and high contrast visual acuity. Corneal first surface wavefront aberrations were calculated from EyeSys topography data using VOL-Pro software v7.00 for a 4.0-mm pupil as a 10th order Zernike expansion and converted into single value metrics. Normal patients were compared to patients with PK using analysis of variance, and linear regression was used to compare wavefront aberration metrics to visual performance.
RESULTS: Patients with PK (n=14, age 41.6 +/- 7.0 years) and normal patients (n=14, age 36.7-9.0 years) were of similar age (F(1, 26) = 2.54, P = .12). Normal patients saw significantly better on all visual performance measures and had better optical performance for total higher order root-mean-square corneal wavefront aberration (mean-SD): PK, 0.67 +/- 0.41 microm; normal, 0.09 +/- 0.02 microm (F(1,26) = 28.41, P < .001) and across all Zernike orders and modes. Wavefront aberrations in PK eyes were dominated by trefoil 0.35 +/- 0.27 microm, coma 0.47 +/- 0.37 microm, spherical aberration 0.17 +/- 0.10 microm, and tetrafoil 0.12 +/- 0.07 microm. The relationships between corneal wavefront aberration and visual performance metrics were strongest for LCVA = 0.30-0.98 Pupil fraction for wavefront (tessellation) -0.04 Half width at half height, R2=0.75.
CONCLUSIONS: In this series, patients with PK had poorer visual performance compared to normal patients, which is due to increased corneal wavefront aberrations. Outcomes research in corneal transplantation should include measurement of wavefront aberrations and visual performance in the contrast domain.

Entities:  

Mesh:

Year:  2006        PMID: 17124891     DOI: 10.3928/1081-597X-20061101-18

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  7 in total

Review 1.  [Application of wavefront analysis in clinical and scientific settings. From irregular astigmatism to aberrations of a higher order--Part II: examples].

Authors:  J Bühren; T Kohnen
Journal:  Ophthalmologe       Date:  2007-11       Impact factor: 1.059

2.  Effect of trabeculectomy on ocular and corneal higher order aberrations.

Authors:  Shima Fukuoka; Shiro Amano; Norihiko Honda; Tatsuya Mimura; Tomohiko Usui; Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2011-07-20       Impact factor: 2.447

3.  The effect of corneal light scatter on vision after penetrating keratoplasty.

Authors:  Sanjay V Patel; Jay W McLaren; David O Hodge; William M Bourne
Journal:  Am J Ophthalmol       Date:  2008-09-06       Impact factor: 5.258

4.  Retinal image quality during accommodation.

Authors:  Norberto López-Gil; Jesson Martin; Tao Liu; Arthur Bradley; David Díaz-Muñoz; Larry N Thibos
Journal:  Ophthalmic Physiol Opt       Date:  2013-07       Impact factor: 3.117

5.  Influence of Overhanging Bleb on Corneal Higher-Order Aberrations after Trabeculectomy.

Authors:  Yu Mizuno; Kazuyuki Hirooka; Yoshiaki Kiuchi
Journal:  J Clin Med       Date:  2021-12-29       Impact factor: 4.241

6.  Improvements in Optical Characteristics after Excision of an Overhanging Bleb Developed following Trabeculectomy.

Authors:  Yu Mizuno; Atsushi Hirota; Kazuyuki Hirooka; Yoshiaki Kiuchi
Journal:  Case Rep Ophthalmol Med       Date:  2021-09-04

7.  Corneal Transplantation in Disease Affecting Only One Eye: Does It Make a Difference to Habitual Binocular Viewing?

Authors:  Praveen K Bandela; PremNandhini Satgunam; Prashant Garg; Shrikant R Bharadwaj
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.